Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in Professional Religious Leaders
NCT02243813Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2015
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of psilocybin, sponsored by Johns Hopkins University. Primary endpoint: Interim Questionnaire at 6 months. Started Mar 2015; status: completed.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT02243813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243813.